Home

Edward M. Md Kaye, CEO: Stoke Therapeutics STOK Sell · Filed 24/05/22

Trade details

Type
Insider sale
Amount
$610,767.54
Shares · price
39,686 sh · $15.39 a share
Held after
29,664 sh
Trade date
24/05/20
Filed
24/05/22
Days to filing
2 days

Sold 57.2% of holdings

Share of holding sold
57.2%

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/20~24/06/19

Edward M. Md Kaye's recent trades

  • Edward M. Md Kaye

    Sell10b5-1 planCytokinetics

    $223.2K

    Filed 06/01

  • Edward M. Md Kaye

    Planned sale10b5-1 planCytokinetics

    $225.1K

    Filed 06/01

  • Edward M. Md Kaye

    Sell10b5-1 planStoke Therapeutics

    $269.1K

    Filed 25/12/10

  • Edward M. Md Kaye

    Sell10b5-1 planStoke Therapeutics

    $120.3K

    Filed 25/12/10

  • Edward M. Md Kaye

    Sell10b5-1 planStoke Therapeutics

    $44.1K

    Filed 25/12/10

Edward M. Md Kaye, CEO — sold $610.8K of Stoke Therapeutics STOK · 57.2% of holdings · 10b5-1 plan | Whalegun